BRIACELL THERAPEUTICS CORP. Liabilities, Noncurrent
BRIACELL THERAPEUTICS CORP. (BCTX) had Liabilities, Noncurrent of $71.85 thousand as of 2026-04-30, per its 10-Q filed 2026-06-09.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LiabilitiesNoncurrent · last filed 2026-06-09
- 2026-04-30: Liabilities, Noncurrent $71.85K.
- 2026-01-31: Liabilities, Noncurrent $195.10K.
- 2025-10-31: Liabilities, Noncurrent $406.87K.
- 2025-07-31: Liabilities, Noncurrent $337.67K.
| Period end | Liabilities, Noncurrent |
|---|---|
| 2026-04-30 | $71.85K 10-Q · filed 2026-06-09 |
| 2026-01-31 | $195.10K 10-Q · filed 2026-03-10 |
| 2025-10-31 | $406.87K 10-Q · filed 2025-12-11 |
| 2025-07-31 | $337.67K 10-Q · filed 2026-06-09 |
| 2025-04-30 | $730.01K 10-Q · filed 2025-06-16 |
| 2025-01-31 | $905.84K 10-Q · filed 2025-03-12 |
| 2024-10-31 | $1.71M 10-Q · filed 2024-12-16 |
| 2024-07-31 | $1.10M 10-K · filed 2025-10-16 |
| 2024-04-30 | $5.68M 10-Q · filed 2024-06-14 |
| 2024-01-31 | $16.62M 10-Q · filed 2024-03-18 |
| 2023-10-31 | $15.06M 10-Q · filed 2023-12-14 |
| 2023-07-31 | $29.14M 10-K · filed 2024-10-29 |
| 2023-04-30 | $34.23M 10-Q · filed 2023-06-14 |
| 2023-01-31 | $34.77M 10-Q · filed 2023-03-16 |
| 2022-10-31 | $27.14M 10-Q · filed 2022-12-14 |
| 2022-07-31 | $31.31M 10-K · filed 2023-10-25 |
| 2021-07-31 | $29.82M 10-K · filed 2022-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |